b-cell non-hodgkins lymphoma
Item
diagnosis of b-cell non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
relapsed or refractory disease
Item
relapsed or refractory disease
boolean
C0277556 (UMLS CUI [1])
previous therapy
Item
previously treated with myeloablative doses of iodine i^131 tositumomab and autologous bone marrow or stem cell transplantation on 1 of the following phase i or ii protocols:
boolean
C1514463 (UMLS CUI [1,1])
C0768182 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C1504389 (UMLS CUI [2,2])
fhcrc-296
Item
fhcrc-296
boolean
fhcrc-521
Item
fhcrc-521
boolean
fhcrc-792
Item
fhcrc-792
boolean
fhcrc-915
Item
fhcrc-915
boolean
ID.8
Item
patient characteristics:
boolean
age
Item
18 and over
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status
boolean
C1520224 (UMLS CUI [1])
ID.11
Item
not specified
boolean
life expectancy
Item
life expectancy
boolean
C0023671 (UMLS CUI [1])
ID.13
Item
not specified
boolean
hematopoietic
Item
hematopoietic
boolean
C0229601 (UMLS CUI [1])
ID.15
Item
not specified
boolean
hepatic
Item
hepatic
boolean
C0205054 (UMLS CUI [1])
ID.17
Item
not specified
boolean
renal
Item
renal
boolean
C0022646 (UMLS CUI [1])
ID.19
Item
not specified
boolean
prior concurrent therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1,1])
C0009429 (UMLS CUI [1,2])
biologic therapy
Item
biologic therapy
boolean
C0005527 (UMLS CUI [1])
ID.22
Item
see disease characteristics
boolean
chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
ID.24
Item
not specified
boolean
endocrine therapy
Item
endocrine therapy
boolean
C0279025 (UMLS CUI [1])
ID.26
Item
not specified
boolean
radiotherapy
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
ID.28
Item
see disease characteristics
boolean
surgery
Item
surgery
boolean
C0543467 (UMLS CUI [1])
ID.30
Item
not specified
boolean